Comparing TB Diagnosis Methods in HIV-Positive Patients
Author Information
Author(s): Lesley Scott, Kerrigan McCarthy, Natasha Gous, Matilda Nduna, Annelies Van Rie, Ian Sanne, Willem F. Venter, Adrian Duse, Wendy Stevens
Primary Institution: University of the Witwatersrand, Johannesburg, South Africa
Hypothesis
The study aims to compare the performance of Xpert MTB/RIF with other nucleic acid amplification technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting.
Conclusion
The Xpert MTB/RIF test has superior performance for rapid diagnosis of Mycobacterium tuberculosis compared to existing methods in an HIV- and TB-endemic region.
Supporting Evidence
- The Xpert MTB/RIF test detected 86% of TB cases compared to 59% for smear microscopy.
- Among HIV-positive individuals, the sensitivity of Xpert MTB/RIF was 84%.
- Xpert MTB/RIF identified 61% of smear-negative, culture-positive samples.
Takeaway
This study looked at different ways to test for tuberculosis in people with HIV, finding that one test, Xpert MTB/RIF, works better and faster than the others.
Methodology
A prospective study was conducted with adults suspected of having TB, comparing the Xpert MTB/RIF test to smear microscopy, liquid culture, and other molecular tests.
Potential Biases
Potential biases may arise from the reliance on a single sputum sample for testing.
Limitations
The study's sample size was limited and may not fully represent the broader population.
Participant Demographics
Mean age was 32.4 years, with 59% male and 70% HIV-positive participants.
Statistical Information
P-Value
p<0.05
Confidence Interval
95% CI 76%–93%
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website